Approvals/TGA/INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack

Approved

STANDARD

INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack

Taiho Pharma Oceania Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 579a8ae1eff50c6f
Product Name: INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack
Artg Id: 375556
Artg Name: INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack
Sponsor: Taiho Pharma Oceania Pty Ltd
Company Detail Path: /organization/taiho-pharma-oceania-pty-ltd
Artg Date: 2021-12-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b8d9b62dc2f52e53ada58e3da7a481c9.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/57bbf60760ce58762e28e49bc1585263.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

579a8ae1eff50c6f

Type

Standard